699 results found

2020 was a busy year at the PTAB. Despite the many issues facing us all during the COVID-19 pandemic, the overall number of AIA-trial filings increased in fiscal year 2020...

It's been a busy few days for Director Vidal and the USPTO, with the Office providing updated guidance on how the PTAB will apply its discretion under Fintiv when considering post-grant petitions...

Alice Corp v. CLS Bank Int'l, 134 S. Ct. 2347 (2014) sent rejections under 35 U.S.C. § 101 skyrocketing from under 10,000 per year prior to the Alice decision to nearly 35,000 the year the Supreme Court...

Patent owners are often faced with the pre-lawsuit decision of whom to sue for patent infringement.

Our previous communications of September 17, 2021, November 19, 2021, and April 27, 2022 (each attached for your reference) provided information on the U.S. Patent and Trademark Office (USPTO)'s...

The Notice of Investigation further indicates that the Office of Unfair Import Investigations will participate as a party in the investigation.

On December 20 the Federal Circuit in Teva Branded Pharmaceutical Products R&D, Inc. (Teva) v. Amneal Pharmaceuticals (Amneal) affirmed the district court's decision that medical devices...

An article by Philippe Signore titled "As the Climate for U.S. Patents Turns Brighter, Now is the Right Time to Invest in These Assets" is published in IPWatchdog.

On May 2, 2023, the Patent Trial and Appeal Board (PTAB) reversed the Examiner's rejection of a claim directed to a method of creating an immobilized DNA library...

On July 22, 2022, the Patent Trial and Appeal Board (PTAB) reversed an examiner's assertion of obviousness in the case of Ex parte Jaeger (Appeal 2021-002641, USSN 15/559,117).

On April 28, 2022, Bell Semiconductor, LLC of Bethlehem, Pennsylvania ("Bell Semic") filed a complaint requesting that the ITC commence an investigation pursuant to section 337.

On June 29, 2021, Chief ALJ Charles E. Bullock issued the public version (Part I, Part II, Part III) of his final initial determination ("ID") finding a violation of section 337...

The Federal Circuit affirmed in-part and vacated in-part the PTAB's (the Board) decision that the petitioner, Medtronic, Inc., had not proven that the challenged patent claims were unpatentable.

On April 29, 2021 the the U.S. Court of Appeals for the Federal Circuit issued its opinion affirming the ITC's finding of a violation of section 337 in Certain Microfluidic Systems...

As we discussed last year, the U.S. Supreme Court's decision in TC Heartland LLC v. Kraft Food Grp. Brands LLC, 137 S. Ct. 1514 (2017) significantly limited where patent infringement actions...

The Federal Circuit affirms the lower court ruling that "half-liquid" translated from the original Italian "semiliquido" is indefinite in IBSA Institut Biochimique, S.A., Altergon, S.A., ...

미국 특허심판원(PTAB)의 자명성 공격이나 미국 특허청(USPTO) 심사관의 거절에 대응하는 일은 까다로울 수 있습니다. KSR v. Teleflex 사건(2007년)에서 대법원은 자명성이라